Skip to main content

Table 2 Association between microRNA-144-3p expression and clinicopathological parameters in lung squamous cell carcinoma, based on The Cancer Genome Atlas data

From: Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data

Clinicopathological feature   n mean ± SD p-value
Tissue Adjacent non-cancerous tissue 44 5.5678 ± 1.27693 < 0.001*
LUSC 332 2.8193 ± 1.40600
Age (years) < 60 59 2.7458 ± 1.32704 0.739
≥60 267 2.8106 ± 1.42109
Gender Female 84 2.8195 ± 1.49697 0.999
Male 248 2.8192 ± 1.37698
Tumor location Central lung 106 2.7551 ± 1.27303 0.848
Peripheral lung 73 2.7968 ± 1.51724
Stage Stage I-II 276 2.8878 ± 1.39556 0.04*
Stage III-IV 53 2.4469 ± 1.41079
T T1-T2 262 2.9023 ± 1.40854 0.035*
T3-T4 70 2.5088 ± 1.36178
N No 213 2.8637 ± 1.43682 0.302
Yes 113 2.6987 ± 1.33482
M No 252 2.7345 ± 1.38222 0.895
Yes 3 2.9144 ± 2.09106
  1. SD Standard deviation, LUSC Lung squamous cell carcinoma
  2. *p < 0.05 was considered statistically significant